Literature DB >> 8664199

Lethal paraneoplastic pemphigus following treatment of chronic lymphocytic leukaemia with fludarabine.

A Bazarbachi, H Bachelez, L Dehen, A Delmer, R Zittoun, L Dubertret.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8664199     DOI： 10.1093/oxfordjournals.annonc.a059294

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  4 in total

1.  Paraneoplastic pemphigus associated with fludarabine use.

Authors:  Ozcan Yildiz; Mustafa Ozguroglu; M Teoman Yanmaz; Hande Turna; Sabiha Gokcen Kursunoglu; Meltem Antonov; Server Serdaroglu; Cuyan Demirkesen; Evin Buyukunal
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

Review 2.  Fludarabine. An update of its pharmacology and use in the treatment of haematological malignancies.

Authors:  J C Adkins; D H Peters; A Markham
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

Review 3.  Achieving optimal outcomes in chronic lymphocytic leukaemia.

Authors:  T J Hamblin
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 4.  Paraneoplastic Pemphigus: Insight into the Autoimmune Pathogenesis, Clinical Features and Therapy.

Authors:  Giovanni Paolino; Dario Didona; Giuseppe Magliulo; Giannicola Iannella; Biagio Didona; Santo Raffaele Mercuri; Elisa Moliterni; Michele Donati; Andrea Ciofalo; Guido Granata; Patricia Ranuzzi; Vincenzo Falasca; Stefano Calvieri
Journal:  Int J Mol Sci       Date:  2017-11-26       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.